Oregon State University researchers have developed a new weapon in the battle against antibiotic-resistant germs – a molecule that neutralizes the bugs’ ability to destroy the antibiotic.
Scientists at OSU were part of an international collaboration that demonstrated the molecule’s ability to inhibit expression of an enzyme that makes bacteria resistant to a wide range of penicillins.
The molecule is a PPMO, short for peptide-conjugated phosphorodiamidate morpholino oligomer. The enzyme it combats is known as New Delhi metallo-beta-lactamase, or NDM-1, and it’s accompanied by additional genes that encode resistance to most if not all antibiotics.
“We’re targeting a resistance mechanism that’s shared by a whole bunch of pathogens,” said Bruce Geller, professor of microbiology in OSU’s College of Science and College of Agricultural Sciences, who’s been researching molecular medicine for more than a decade. “It’s the same gene in different types of bacteria, so you only have to have one PPMO that’s effective for all of them, which is different than other PPMOs that are genus specific.”
The Oregon State study showed that in vitro the new PPMO restored the ability of an antibiotic — in this case meropenem, an ultra-broad-spectrum drug of the carbapenem class — to fight three different genera of bacteria that express NDM-1. The research also demonstrated that a combination of the PPMO and meropenem was effective in treating mice infected with a pathogenic strain of E. coli that is NDM-1 positive.
Results of the study, supported by a grant from the National Institutes of Health, were recently published in the Journal of Antimicrobial Chemotherapy.
Geller says the PPMO will likely be ready for testing in humans in about three years.
“We’ve lost the ability to use many of our mainstream antibiotics,” Geller said. “Everything’s resistant to them now. That’s left us to try to develop new drugs to stay one step ahead of the bacteria, but the more we look the more we don’t find anything new. So that’s left us with making modifications to existing antibiotics, but as soon as you make a chemical change, the bugs mutate and now they’re resistant to the new, chemically modified antibiotic.”
That progression, Geller explains, made the carbapenems, the most advanced penicillin-type antibiotic, the last line of defense against bacterial infection.
“The significance of NDM-1 is that it is destroys carbapenems, so doctors have had to pull out an antibiotic, colistin, that hadn’t been used in decades because it’s toxic to the kidneys,” Geller said. “That is literally the last antibiotic that can be used on an NDM-1-expressing organism, and we now have bacteria that are completely resistant to all known antibiotics. But a PPMO can restore susceptibility to antibiotics that have already been approved, so we can get a PPMO approved and then go back and use these antibiotics that had become useless.”
Receive an email update when we add a new ANTIBIOTIC RESISTANCE article.
The Latest on: Antibiotic resistance
via Google News
The Latest on: Antibiotic resistance
- Columbus hospitals train South African pharmacists to stem antibiotic-resistant diseases in newbornson August 17, 2019 at 3:20 am
After 23 newborns died of a superbug infection at Chris Hani Baragwanath Hospital in South Africa in January 2018, the third-largest hospital in the world turned to Ohio State University's Wexner ...
- Spraying Antibiotics to Fight Citrus Scourge Doesn’t Help, Study Findson August 16, 2019 at 2:06 pm
But public health advocates reacted with alarm, warning that the large-scale use of medically important drugs in agriculture could help fuel antibiotic resistance in humans. Now a new study by citrus ...
- How a new antibiotic destroys extremely drug-resistant tuberculosison August 16, 2019 at 6:25 am
The Food and Drug Administration on Wednesday approved a new antibiotic that, when combined with two existing antibiotics, can tackle the most formidable and deadly forms of tuberculosis.
- Antibiotic Resistance Thwarted with Biosurfactanton August 16, 2019 at 5:13 am
Pseudomonas aeruginosa-produced rhamnolipids target the plasma membrane of Staphylococcus aureus (labeled here in red) to increase permeability to aminoglycoside antibiotics. [Conlon Lab, UNC School ...
- FDA Finds Unexpected Antibiotic Resistance Genes in ‘Gene-Edited’ Dehorned Cattleon August 15, 2019 at 11:04 am
Gene-editing is seen by many as the ultimate in precision breeding. Polled cattle, whose horns have been genetically removed, have been presented as exemplars of this — a socially beneficial use of ...
- Scientists find powerful potential weapon to overcome antibiotic resistanceon August 15, 2019 at 10:35 am
Staphylococcus aureus bacteria are a major cause of serious infections that often persist despite antibiotic treatment, but scientists at the UNC School of Medicine have now discovered a way to ...
- FDA approves new antibiotic for drug-resistant tuberculosison August 14, 2019 at 2:51 pm
Aug. 14 (UPI) --The U.S. Food and Drug Administration approved a new antibiotic for highly drug-resistant tuberculosis. The agency approved the use of pretomanid tablets, developed by global nonprofit ...
- New antibiotic approved for drug-resistant tuberculosison August 14, 2019 at 11:27 am
The Food and Drug Administration on Wednesday approved a new drug for highly drug-resistant tuberculosis, the world’s leading infectious cause of death. Tuberculosis kills 1.6 million people a year, ...
- Antibiotics for UTIs: Recipe for Resistance Down the Road?on August 13, 2019 at 4:21 pm
British patients diagnosed with urinary tract infections (UTIs) rarely had any testing performed before receiving antibiotics, a records analysis indicated. Almost 86% of patients received antibiotics ...
via Bing News